Black Bird Biotech, Inc. (CIK: 0001409999) EDGAR, Information, Filings... CompaniesBIO.Com

Black Bird Biotech, Inc.

Mailing address
3505 YUCCA DRIVE, SUITE 104, FLOWER MOUND, Nevada, 75028
Phone
833-223-4204
State location
Texas
State of incorporation
Nevada
Fiscal year end
December 31
SIC
3990 - (CF Office: Office of Manufacturing) MISCELLANEOUS MANUFACTURING INDUSTRIES
Filings
N/A

Black Bird Biotech, Inc. (CIK: 0001409999) is an American company incorporated in the state of Texas. Head office is located at 3505 YUCCA DRIVE, SUITE 104, FLOWER MOUND, Texas, 75028. Work in the industry 3990 - (CF Office: Office of Manufacturing) MISCELLANEOUS MANUFACTURING INDUSTRIES. Black Bird Biotech, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

Digital Development Partners, Inc. from 2009-16-Oct to 2021-21-Jun
Cyprium Resources Inc. from 2007-10-Sep to 2009-12-Aug

Owner	Filings	Transaction Date	Type of Owner
Collins Jeffrey A	0001460664	Jan-15-2009	director, 10 percent owner, officer: President
Shea Robert Edward	0001446438	Sep-12-2008	director, 10 percent owner, officer: President, CEO, CFO, CAO
Sutherland John James	0001430121	Sep-20-2007	director, 10 percent owner, officer: President, CEO, CFO & CAO

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Black Bird Biotech, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001477932-24-003076 (34 Act) Size: 30 KB	May-16-2024	000-52828 24956885
NT 10-K	Document	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001477932-24-001643 (34 Act) Size: 28 KB	Apr-01-2024	000-52828 24805697
SC 14F1	Document	Statement regarding change in majority of directors pursuant to Rule 14f-1 Acc-no: 0001477932-24-001047 (34 Act) Size: 146 KB	Mar-06-2024	005-91248 24723275
8-K	Document	Current report filing Acc-no: 0001477932-24-001034 (34 Act) Size: 9040 KB	Mar-05-2024	000-52828 24720466
8-K	Document	Current report filing Acc-no: 0001477932-23-009323 (34 Act) Size: 197 KB	Dec-22-2023	000-52828 231510722
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001477932-23-008686 (34 Act) Size: 3765 KB	Nov-20-2023	000-52828 231422666
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001477932-23-008470 (34 Act) Size: 28 KB	Nov-15-2023	000-52828 231408352
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001477932-23-006351 (34 Act) Size: 5188 KB	Aug-21-2023	000-52828 231190202
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001477932-23-006069 (34 Act) Size: 33 KB	Aug-14-2023	000-52828 231169233
DEF 14C	Document	Definitive information statements Acc-no: 0001477932-23-004142 (34 Act) Size: 102 KB	Jun-01-2023	000-52828 23982629
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001477932-23-003857 (34 Act) Size: 3477 KB	May-22-2023	000-52828 23945179
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001477932-23-003549 (34 Act) Size: 30 KB	May-15-2023	000-52828 23921413
PRER14C	Document	Preliminary revised information statements Acc-no: 0001477932-23-003271 (34 Act) Size: 101 KB	May-11-2023	000-52828 23908575
PRE 14C	Document	Preliminary information statement not related to a contested matter or merger/acquisition Acc-no: 0001477932-23-003110 (34 Act) Size: 97 KB	May-05-2023	000-52828 23890366
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001477932-23-002292 (33 Act) Size: 1138 KB	Apr-06-2023	333-269630 23804514
EFFECT	Document	Acc-no: 9999999995-23-000818 (33 Act) Size: 1 KB	Apr-04-2023	333-269630 23801080
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001477932-23-002143 ( Act) Size: 5 KB	Mar-31-2023
S-1/A	Document	Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001477932-23-001725 (33 Act) Size: 6492 KB	Mar-24-2023	333-269630 23759166
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001477932-23-001598 (34 Act) Size: 6219 KB	Mar-21-2023	000-52828 23747796
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001477932-23-001246 ( Act) Size: 5 KB	Feb-27-2023

Recent 20 filings. View all Black Bird Biotech, Inc. filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Black Bird Biotech, Inc. overview
Black Bird Biotech, Inc. job
Black Bird Biotech, Inc. stock
Black Bird Biotech, Inc. ownership
Black Bird Biotech, Inc. CEO
Black Bird Biotech, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.